semaglutide compounding news november 2025 The FDA has received reports of adverse events after patients used compounded versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved Compound versions of GLP-1 drugs

Many types of neuroprotective agents, neurocognitive agents, peptides, and antioxidant infusions can also help neurocognitive recovery, while some modulators of BDNF and VEGF remain experimental, and stem cell therapies continue to be researched and optimized for neuroprotection and brain recovery

The Infusion Providers Alliance was informed about the policy before it went into effect and sent a letter on June 12 to Aetna outlining the groups concerns, highlighting potential patient care, cost, legal, and supply chain issues

Contact your care team or manage changes through your account dashboard

Whether youre currently using GLP-1 medications, considering starting them, or simply want to ensure your dental care is as comprehensive as possible, were here to provide the expert, compassionate care you deserve

J Geriatr Psychiatry Neurol 25:4350

A combination of bioactive chemicals in female hop flowers may cause people to feel sleepy